Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiologists | 2 | 2025 | 80 | 1.640 |
Why?
|
| Eye Movements | 4 | 2017 | 82 | 1.310 |
Why?
|
| Cues | 4 | 2017 | 73 | 1.310 |
Why?
|
| Cocaine-Related Disorders | 2 | 2017 | 82 | 1.010 |
Why?
|
| Learning | 2 | 2023 | 171 | 0.980 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2025 | 16 | 0.940 |
Why?
|
| Radiography, Thoracic | 1 | 2025 | 110 | 0.900 |
Why?
|
| Diagnostic Errors | 1 | 2025 | 94 | 0.890 |
Why?
|
| Attention | 3 | 2016 | 146 | 0.730 |
Why?
|
| Craving | 3 | 2017 | 36 | 0.640 |
Why?
|
| Lung Neoplasms | 1 | 2025 | 584 | 0.630 |
Why?
|
| Saccades | 3 | 2016 | 14 | 0.600 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2025 | 1507 | 0.560 |
Why?
|
| Reward | 2 | 2007 | 83 | 0.520 |
Why?
|
| Volition | 1 | 2016 | 10 | 0.520 |
Why?
|
| Anxiety Disorders | 1 | 2017 | 186 | 0.500 |
Why?
|
| Depressive Disorder | 1 | 2017 | 279 | 0.470 |
Why?
|
| Cognition | 3 | 2017 | 454 | 0.470 |
Why?
|
| Cognition Disorders | 1 | 2015 | 215 | 0.430 |
Why?
|
| Smoking | 1 | 2015 | 826 | 0.350 |
Why?
|
| Visual Perception | 2 | 2005 | 41 | 0.300 |
Why?
|
| Psychomotor Performance | 3 | 2006 | 133 | 0.290 |
Why?
|
| Heroin Dependence | 2 | 2017 | 22 | 0.280 |
Why?
|
| Models, Psychological | 1 | 2007 | 94 | 0.270 |
Why?
|
| Punishment | 1 | 2006 | 2 | 0.270 |
Why?
|
| Models, Neurological | 1 | 2007 | 79 | 0.270 |
Why?
|
| Buprenorphine, Naloxone Drug Combination | 2 | 2017 | 25 | 0.270 |
Why?
|
| Choice Behavior | 1 | 2007 | 78 | 0.260 |
Why?
|
| Opiate Substitution Treatment | 3 | 2017 | 187 | 0.260 |
Why?
|
| Opioid-Related Disorders | 3 | 2018 | 456 | 0.260 |
Why?
|
| Adult | 10 | 2018 | 15683 | 0.250 |
Why?
|
| Male | 10 | 2025 | 27747 | 0.230 |
Why?
|
| Female | 10 | 2025 | 30724 | 0.230 |
Why?
|
| Illusions | 1 | 2003 | 1 | 0.220 |
Why?
|
| Humans | 16 | 2025 | 59389 | 0.220 |
Why?
|
| Frontal Lobe | 1 | 2001 | 64 | 0.180 |
Why?
|
| Substance-Related Disorders | 2 | 2018 | 687 | 0.180 |
Why?
|
| Young Adult | 5 | 2017 | 4272 | 0.180 |
Why?
|
| Reaction Time | 3 | 2006 | 119 | 0.170 |
Why?
|
| Clinical Competence | 1 | 2025 | 683 | 0.170 |
Why?
|
| Lung | 1 | 2025 | 920 | 0.160 |
Why?
|
| Memantine | 2 | 2017 | 22 | 0.160 |
Why?
|
| Prescription Drug Overuse | 1 | 2018 | 7 | 0.160 |
Why?
|
| Brain | 1 | 2007 | 1488 | 0.150 |
Why?
|
| Eye Movement Measurements | 1 | 2017 | 20 | 0.140 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2017 | 23 | 0.140 |
Why?
|
| Psychological Tests | 1 | 2017 | 45 | 0.140 |
Why?
|
| Diagnosis, Dual (Psychiatry) | 1 | 2017 | 79 | 0.140 |
Why?
|
| Prospective Studies | 1 | 2025 | 3067 | 0.140 |
Why?
|
| Interview, Psychological | 1 | 2017 | 73 | 0.140 |
Why?
|
| Executive Function | 1 | 2017 | 61 | 0.140 |
Why?
|
| Drug Prescriptions | 1 | 2018 | 168 | 0.140 |
Why?
|
| Cocaine | 1 | 2017 | 96 | 0.140 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2017 | 74 | 0.130 |
Why?
|
| Affect | 1 | 2017 | 123 | 0.130 |
Why?
|
| Drug Overdose | 1 | 2018 | 126 | 0.130 |
Why?
|
| Methadone | 1 | 2017 | 127 | 0.130 |
Why?
|
| Chronic Pain | 1 | 2018 | 134 | 0.130 |
Why?
|
| Middle Aged | 3 | 2025 | 16314 | 0.130 |
Why?
|
| Aging | 1 | 2001 | 710 | 0.120 |
Why?
|
| Naloxone | 1 | 2015 | 57 | 0.120 |
Why?
|
| Motor Activity | 1 | 2017 | 333 | 0.120 |
Why?
|
| Narcotic Antagonists | 1 | 2015 | 121 | 0.110 |
Why?
|
| Adolescent | 4 | 2017 | 5838 | 0.110 |
Why?
|
| Analgesics, Opioid | 1 | 2017 | 483 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2017 | 527 | 0.100 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 1479 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2018 | 720 | 0.090 |
Why?
|
| Veterans | 1 | 2017 | 728 | 0.080 |
Why?
|
| Tobacco Use Disorder | 1 | 2010 | 243 | 0.070 |
Why?
|
| Alcoholism | 1 | 2010 | 310 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 117 | 0.060 |
Why?
|
| Photic Stimulation | 1 | 2005 | 89 | 0.060 |
Why?
|
| Age Factors | 2 | 2017 | 1504 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2006 | 589 | 0.060 |
Why?
|
| Smoking Cessation | 1 | 2010 | 541 | 0.060 |
Why?
|
| Superior Colliculi | 1 | 2003 | 12 | 0.060 |
Why?
|
| Visual Cortex | 1 | 2003 | 27 | 0.050 |
Why?
|
| Functional Laterality | 1 | 2001 | 133 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2001 | 371 | 0.040 |
Why?
|
| Colombia | 1 | 2017 | 17 | 0.040 |
Why?
|
| Needle Sharing | 1 | 2017 | 13 | 0.040 |
Why?
|
| Psychotherapy, Group | 1 | 2017 | 33 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 354 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 451 | 0.030 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2017 | 119 | 0.030 |
Why?
|
| Comorbidity | 1 | 2018 | 1078 | 0.030 |
Why?
|
| Recurrence | 1 | 2015 | 602 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 805 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2015 | 715 | 0.030 |
Why?
|
| Massachusetts | 1 | 2018 | 2019 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2001 | 2052 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 2516 | 0.020 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2010 | 104 | 0.020 |
Why?
|
| Neoplasms | 1 | 2018 | 1231 | 0.020 |
Why?
|
| Behavior Therapy | 1 | 2010 | 161 | 0.020 |
Why?
|
| Child | 1 | 2017 | 4189 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2018 | 6071 | 0.020 |
Why?
|
| Aged | 1 | 2001 | 13406 | 0.020 |
Why?
|